FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W137447096> ?p ?o ?g. }

• W137447096 abstract "Dear Sir,We have read with interest the paper by Liumbruno et al., which deals with both the rationale and major concerns of transfusion practice in elective surgery1. As anaesthesiologists we particularly appreciated the reported multifaceted recommendations on the intra-operative transfusion approach. Most of the time anaesthesiologists are fully responsible for the decision to transfuse as well as for the transfusion itself. Clear and easy-to-use guidelines for blood component therapy are, therefore, very welcome.Well-examined and detailed recommendations are made on the evaluation and monitoring of anaemia, blood loss, intra-operative blood salvage, transfusion threshold for red blood cells, platelets, fresh-frozen plasma, fluids, cryoprecipitate, fibrinogen, antithrombin, as well as appropriate and inappropriate indications. However, among the numerous suggestions made, the need for point-of-care coagulation testing in cases of persistent bleeding is not mentioned. Strict, bedside monitoring of haemostasis is, in fact, essential in patients with a complex and rapidly changing coagulation profile. In addition to the mentioned therapeutic interventions to control and rationalise blood and blood product usage, we believe that thromboelastography, which provides rapid and reliable information on coagulation deficits, deserves attention.Thromboelastography is now widely used as a near-site monitor of haemostasis, and, even though it remains relatively unvalidated compared with other laboratory-based routine coagulation studies, it plays a leading role among anaesthesiologists in the management of difficult haemostasis2.Conventional coagulation screens (prothrombin time, partial thromboplastin time, platelet count and fibrinogen concentrations) are frequently inadequate for the purpose of intra-operative monitoring of unpredictable coagulation. During massive haemorrhage conventional laboratory tests require too much time, and if significant bleeding continues, when the laboratory data are finally available the patient’s coagulation profile may be completely different. In these circumstances anaesthesiologists should be offered a point-of-care clotting analyser capable of providing reliable near real-time results.Conventional Thromboelastography (TEG) provides information starting with the formation of the fibrin-platelet clot and continues to generate data as clotting continues through to eventual clot lysis or retraction. TEG assists in the differential diagnosis of coagulopathy, differentiates surgical from non-surgical bleeding and helps to indicate the most adequate blood transfusion products and pharmacological agents to achieve optimal biological haemostasis. Although it cannot identify the individual coagulation factors (e.g. factors VIII, IX and X), inhibitors (e.g. antithrombin, protein C and protein S) or activators (e.g. thromboxane A2 and ADP), the time, rate, strength and stability of the clot indicate whether the patient has a normal, hypocoagulable or hypercoagulable coagulation profile. Furthermore, the potential interference between blood and blood components and intravenous crystalloids and/or colloids are also detected by TEG.Cardiovascular, urological, obstetric and trauma surgery still requires a significant amount of blood components and is very demanding on the local blood bank. In various studies blood usage has been demonstrated to be significantly less when based on TEG information than when conventional “clinician-directed” management is used2,3. Using thromboelastography variables has led to a substantial decrease in blood component transfusion in many surgical settings. During liver transplantation the amount of fresh-frozen plasma administered was significantly reduced with the use of TEG-guided criteria for transfusion4. In cardiac surgery TEG may be useful for predicting patients who are likely to bleed post-operatively and, more importantly, it can guide transfusion therapy algorithms in order to prevent bleeding5.TEG, rotative thromboelastometry (ROTEM®), and Sonoclot® coagulation analysers provide global information on the dynamics of clot development, stabilisation and dissolution which reflect in vivo haemostasis. Another advantage of point-of-care coagulation monitoring is further reducing empirical transfusions in high-risk patients already being treated prophylactically with various drugs (e.g. antiplatelet agents, low molecular weight heparin, antifibrinolytics).The results of TEG/ROTEM® should, however, be carefully interpreted and correlated to the patient’s clinical condition. This is due to a number of limitations of these monitoring systems, such as the measurement of haemostasis under static conditions in vitro, the depiction of clot development as a whole blood analysis of the coagulation status, and their inability to distinguish multiple coagulation deficiencies easily. No single TEG/ROTEM® parameter correlates directly with laboratory coagulation tests but, when combined, they enable identification of specific component deficiencies.Bed-side coagulation monitoring systems are still underused in the operating room, despite their recognised benefits. Costs, untrained or under-trained physicians, poorly controlled quality checking and limited interest in blood-saving are among the principal causes of their relatively uncommon use.Future improvements in point-of-care coagulation analysers, with easier handling of blood samples, full automation, simultaneous testing with multiple activators, integrated analysis software and increased comparability with laboratory values will provide more reliable results and promote the introduction of these devices into clinical practice.As reported by Afshari et al.3, there is still a lack of evidence that TEG or ROTEM® improves morbidity or mortality in patients with severe blood loss; however, application of a TEG- or ROTEM®-guided transfusion strategy was found to have a statistically significant effect on predefined outcomes such as reduced bleeding and reduced number of patients requiring transfusion of both platelets and fresh-frozen plasma.In conclusion, adopting a TEG- or ROTEM®-based algorithm in the routine management of patients with haemostatic abnormality, and in those with surgery or transfusion-related coagulopathy may help to improve clinical outcome and reduce the potential risks of transfusion-related complications. Supporting ongoing transfusion therapy with the aid of visco-elastic whole blood assays proves advantageous in maintaining normal haemostatic competence until surgical haemostasis is achieved. This strategy may lead to a diminished transfusion threshold compared to that indicated by the prothrombin time/International Normalised Ratio and thus reduce the need for allogeneic blood products." @default.
• W137447096 created "2016-06-24" @default.
• W137447096 creator A5006338020 @default.
• W137447096 creator A5076047346 @default.
• W137447096 creator A5081632349 @default.
• W137447096 date "2012-07-01" @default.
• W137447096 modified "2023-09-23" @default.
• W137447096 title "Intra-operative transfusion management: the usefulness of point-of-care coagulation monitoring." @default.
• W137447096 doi "https://doi.org/10.2450/2012.0088-11" @default.
• W137447096 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3417744" @default.
• W137447096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22337271" @default.
• W137447096 hasPublicationYear "2012" @default.
• W137447096 type Work @default.
• W137447096 sameAs 137447096 @default.
• W137447096 citedByCount "0" @default.
• W137447096 crossrefType "posted-content" @default.
• W137447096 hasAuthorship W137447096A5006338020 @default.
• W137447096 hasAuthorship W137447096A5076047346 @default.
• W137447096 hasAuthorship W137447096A5081632349 @default.
• W137447096 hasConcept C126322002 @default.
• W137447096 hasConcept C141071460 @default.
• W137447096 hasConcept C142724271 @default.
• W137447096 hasConcept C16124881 @default.
• W137447096 hasConcept C177713679 @default.
• W137447096 hasConcept C26809991 @default.
• W137447096 hasConcept C2777396833 @default.
• W137447096 hasConcept C2777664302 @default.
• W137447096 hasConcept C2778258694 @default.
• W137447096 hasConcept C2778261982 @default.
• W137447096 hasConcept C2778382381 @default.
• W137447096 hasConcept C2778589496 @default.
• W137447096 hasConcept C2779036427 @default.
• W137447096 hasConcept C2779792907 @default.
• W137447096 hasConcept C2779817106 @default.
• W137447096 hasConcept C2780014101 @default.
• W137447096 hasConcept C2780434524 @default.
• W137447096 hasConcept C51915194 @default.
• W137447096 hasConcept C66112548 @default.
• W137447096 hasConcept C71924100 @default.
• W137447096 hasConcept C89560881 @default.
• W137447096 hasConceptScore W137447096C126322002 @default.
• W137447096 hasConceptScore W137447096C141071460 @default.
• W137447096 hasConceptScore W137447096C142724271 @default.
• W137447096 hasConceptScore W137447096C16124881 @default.
• W137447096 hasConceptScore W137447096C177713679 @default.
• W137447096 hasConceptScore W137447096C26809991 @default.
• W137447096 hasConceptScore W137447096C2777396833 @default.
• W137447096 hasConceptScore W137447096C2777664302 @default.
• W137447096 hasConceptScore W137447096C2778258694 @default.
• W137447096 hasConceptScore W137447096C2778261982 @default.
• W137447096 hasConceptScore W137447096C2778382381 @default.
• W137447096 hasConceptScore W137447096C2778589496 @default.
• W137447096 hasConceptScore W137447096C2779036427 @default.
• W137447096 hasConceptScore W137447096C2779792907 @default.
• W137447096 hasConceptScore W137447096C2779817106 @default.
• W137447096 hasConceptScore W137447096C2780014101 @default.
• W137447096 hasConceptScore W137447096C2780434524 @default.
• W137447096 hasConceptScore W137447096C51915194 @default.
• W137447096 hasConceptScore W137447096C66112548 @default.
• W137447096 hasConceptScore W137447096C71924100 @default.
• W137447096 hasConceptScore W137447096C89560881 @default.
• W137447096 hasLocation W1374470961 @default.
• W137447096 hasOpenAccess W137447096 @default.
• W137447096 hasPrimaryLocation W1374470961 @default.
• W137447096 hasRelatedWork W1563036944 @default.
• W137447096 hasRelatedWork W1566760294 @default.
• W137447096 hasRelatedWork W1967351098 @default.
• W137447096 hasRelatedWork W1981829645 @default.
• W137447096 hasRelatedWork W1995418386 @default.
• W137447096 hasRelatedWork W2022291683 @default.
• W137447096 hasRelatedWork W2031100231 @default.
• W137447096 hasRelatedWork W2051791079 @default.
• W137447096 hasRelatedWork W2071898999 @default.
• W137447096 hasRelatedWork W2073200742 @default.
• W137447096 hasRelatedWork W2127726147 @default.
• W137447096 hasRelatedWork W2133124592 @default.
• W137447096 hasRelatedWork W2135033232 @default.
• W137447096 hasRelatedWork W2159483735 @default.
• W137447096 hasRelatedWork W2363556660 @default.
• W137447096 hasRelatedWork W2480550451 @default.
• W137447096 hasRelatedWork W2924840591 @default.
• W137447096 hasRelatedWork W3096713852 @default.
• W137447096 hasRelatedWork W3128517836 @default.
• W137447096 hasRelatedWork W2740598766 @default.
• W137447096 isParatext "false" @default.
• W137447096 isRetracted "false" @default.
• W137447096 magId "137447096" @default.
• W137447096 workType "article" @default.